Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Angiotensin IV is induced in experimental autoimmune encephalomyelitis but fails to influence the disease.

Manzel A, Domenig O, Ambrosius B, Kovacs A, Stegbauer J, Poglitsch M, Mueller DN, Gold R, Linker RA.

J Neuroimmune Pharmacol. 2014 Sep;9(4):533-43. doi: 10.1007/s11481-014-9548-y. Epub 2014 May 23.

PMID:
24854706
[PubMed - in process]
2.

T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.

Zheng H, Zhang H, Liu F, Qi Y, Jiang H.

Immunol Lett. 2014 Jan-Feb;157(1-2):38-44. doi: 10.1016/j.imlet.2013.11.001. Epub 2013 Nov 9.

PMID:
24220208
[PubMed - indexed for MEDLINE]
3.

Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis.

York NR, Mendoza JP, Ortega SB, Benagh A, Tyler AF, Firan M, Karandikar NJ.

J Autoimmun. 2010 Aug;35(1):33-44. doi: 10.1016/j.jaut.2010.01.003. Epub 2010 Feb 20.

PMID:
20172692
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.

Stegbauer J, Lee DH, Seubert S, Ellrichmann G, Manzel A, Kvakan H, Muller DN, Gaupp S, Rump LC, Gold R, Linker RA.

Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14942-7. doi: 10.1073/pnas.0903602106. Epub 2009 Aug 19.

PMID:
19706425
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.

Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C.

Glia. 2001 Nov;36(2):220-34. Review.

PMID:
11596130
[PubMed - indexed for MEDLINE]
6.

The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease.

Ben-Nun A, Mendel I, Bakimer R, Fridkis-Hareli M, Teitelbaum D, Arnon R, Sela M, Kerlero de Rosbo N.

J Neurol. 1996 Apr;243(4 Suppl 1):S14-22.

PMID:
8965116
[PubMed - indexed for MEDLINE]
8.

Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.

Pifarré P, Gutierrez-Mecinas M, Prado J, Usero L, Roura-Mir C, Giralt M, Hidalgo J, García A.

Exp Neurol. 2014 Jan;251:58-71. doi: 10.1016/j.expneurol.2013.10.021. Epub 2013 Nov 7.

PMID:
24211383
[PubMed - indexed for MEDLINE]
9.

Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.

Buhler LA, Samara R, Guzman E, Wilson CL, Krizanac-Bengez L, Janigro D, Ethell DW.

BMC Neurosci. 2009 Mar 6;10:17. doi: 10.1186/1471-2202-10-17.

PMID:
19267908
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.

Matsumoto Y, Park IK, Hiraki K, Ohtani S, Kohyama K.

Immunology. 2009 Sep;128(1 Suppl):e250-61. doi: 10.1111/j.1365-2567.2008.02955.x. Epub 2008 Oct 29.

PMID:
19175799
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.

Abdul-Majid KB, Stefferl A, Bourquin C, Lassmann H, Linington C, Olsson T, Kleinau S, Harris RA.

Scand J Immunol. 2002 Jan;55(1):70-81.

PMID:
11841694
[PubMed - indexed for MEDLINE]
13.

Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.

Leadbetter EA, Bourque CR, Devaux B, Olson CD, Sunshine GH, Hirani S, Wallner BP, Smilek DE, Happ MP.

J Immunol. 1998 Jul 1;161(1):504-12.

PMID:
9647262
[PubMed - indexed for MEDLINE]
Free Article
14.

Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells.

Kap YS, Smith P, Jagessar SA, Remarque E, Blezer E, Strijkers GJ, Laman JD, Hintzen RQ, Bauer J, Brok HP, 't Hart BA.

J Immunol. 2008 Feb 1;180(3):1326-37.

PMID:
18209026
[PubMed - indexed for MEDLINE]
Free Article
16.

Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.

Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A.

Tohoku J Exp Med. 2007 Dec;213(4):329-39.

PMID:
18075237
[PubMed - indexed for MEDLINE]
Free Article
17.

Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.

Fissolo N, Costa C, Nurtdinov RN, Bustamante MF, Llombart V, Mansilla MJ, Espejo C, Montalban X, Comabella M.

J Neuroinflammation. 2012 Jun 22;9:139. doi: 10.1186/1742-2094-9-139.

PMID:
22727044
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.

Eltayeb S, Berg AL, Lassmann H, Wallström E, Nilsson M, Olsson T, Ericsson-Dahlstrand A, Sunnemark D.

J Neuroinflammation. 2007 May 7;4:14.

PMID:
17484785
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro.

Kramár EA, Armstrong DL, Ikeda S, Wayner MJ, Harding JW, Wright JW.

Brain Res. 2001 Apr 6;897(1-2):114-21.

PMID:
11282364
[PubMed - indexed for MEDLINE]
20.

Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.

de Lago E, Moreno-Martet M, Cabranes A, Ramos JA, Fernández-Ruiz J.

Neuropharmacology. 2012 Jun;62(7):2299-308. doi: 10.1016/j.neuropharm.2012.01.030. Epub 2012 Feb 8.

PMID:
22342378
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk